HLS Therapeutics Inc Cash Flow-to-Debt Ratio
HLS Therapeutics Inc cash flow-to-debt ratio. HLS Therapeutics Inc (HLS) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2025, meaning its operating cash flow of CA$6.44 Million could theoretically repay 0% of its total liabilities (CA$75.72 Million) in one year. Check HLS Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of HLS Therapeutics Inc (1996–2025)
Cash flow-to-debt ratio of HLS Therapeutics Inc from 1996 to 2025. Historical debt coverage capacity for HLS Therapeutics Inc across 30 annual periods. Check HLS Therapeutics Inc (HLS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
HLS Therapeutics Inc Cash Flow-to-Debt Ratio by Year (1996–2025)
HLS Therapeutics Inc cash flow-to-debt ratio by year from 1996 to 2025. Year-by-year debt coverage analysis for HLS Therapeutics Inc. For the full cash flow conversion analysis, see HLS Therapeutics Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | CA$16.02 Million | CA$75.72 Million | ▲ +134.1% |
| 2024 | 0.09x | CA$8.00 Million | CA$88.56 Million | ▼ -36.3% |
| 2023 | 0.14x | CA$15.79 Million | CA$111.36 Million | ▼ -2.6% |
| 2022 | 0.15x | CA$16.94 Million | CA$116.33 Million | ▲ +2.1% |
| 2021 | 0.14x | CA$16.43 Million | CA$115.17 Million | ▲ +105.6% |
| 2020 | 0.07x | CA$9.34 Million | CA$134.66 Million | ▼ -62.8% |
| 2019 | 0.19x | CA$26.41 Million | CA$141.47 Million | ▼ -15.7% |
| 2018 | 0.22x | CA$32.75 Million | CA$147.94 Million | ▲ +66.4% |
| 2017 | 0.13x | CA$27.17 Million | CA$204.26 Million | ▲ +167.6% |
| 2016 | -0.20x | CA$-108.62K | CA$552.04K | ▲ +96.2% |
| 2015 | -5.15x | CA$-2.94 Million | CA$572.17K | ▼ -479.2% |
| 2014 | 1.36x | CA$18.21 Million | CA$13.42 Million | ▲ +7.5% |
| 2013 | 1.26x | CA$18.03 Million | CA$14.29 Million | ▼ -48.4% |
| 2012 | 2.44x | CA$21.23 Million | CA$8.69 Million | ▲ +83.4% |
| 2011 | 1.33x | CA$17.92 Million | CA$13.45 Million | ▼ -35.3% |
| 2010 | 2.06x | CA$25.06 Million | CA$12.17 Million | ▲ +578.6% |
| 2009 | 0.30x | CA$5.32 Million | CA$17.54 Million | ▼ -4.2% |
| 2008 | 0.32x | CA$5.55 Million | CA$17.53 Million | ▼ -59.8% |
| 2007 | 0.79x | CA$21.98 Million | CA$27.90 Million | ▲ +1973.8% |
| 2006 | 0.04x | CA$703.50K | CA$18.52 Million | ▼ -95.7% |
| 2005 | 0.88x | CA$12.50 Million | CA$14.18 Million | ▲ +309.6% |
| 2004 | 0.22x | CA$2.49 Million | CA$11.56 Million | ▼ -35.1% |
| 2003 | 0.33x | CA$4.92 Million | CA$14.82 Million | ▼ -80.3% |
| 2002 | 1.68x | CA$7.01 Million | CA$4.17 Million | ▲ +234.4% |
| 2001 | 0.50x | CA$2.98 Million | CA$5.92 Million | ▲ +0.1% |
| 2000 | 0.50x | CA$6.59 Million | CA$13.10 Million | ▲ +157.5% |
| 1999 | 0.20x | CA$4.56 Million | CA$23.34 Million | ▲ +5450.3% |
| 1998 | 0.00x | CA$-64.99K | CA$17.81 Million | ▼ -101.6% |
| 1997 | 0.23x | CA$5.52 Million | CA$24.04 Million | ▼ -75.0% |
| 1996 | 0.92x | CA$9.27 Million | CA$10.09 Million | — |